Investing.com -- It’s been a mixed week for equities, with the rise so far in Friday’s session putting the S&P on track to close flat for the week, while the Nasdaq would post a 0.2% increase.
Here are our stocks of the week:
Micron
Micron’s big beat and raise helped turn market sentiment on the AI trade towards the end of the week.
The stock posted a more than 10% gain on Thursday and has so far added 6.9% on Friday, putting it on track for a weekly rise and a new all-time high close.
The memory chipmaker forecast a sharp jump in revenue and earnings, and all-time high margins for the current quarter, as higher memory prices and demand tied to AI workloads drove record first-quarter results.
Morgan Stanley analyst Joseph Moore said in a note following the results that the company delivered one of the largest revenue and profit upside surprises in U.S. semiconductor history.
“As long as the AI music plays, we believe this is going to keep happening, as AI CAGRs off of ever bigger numbers are now pressuring the overall semi supply and demand,” wrote Moore.
Nike
Nike shareholders had a Friday to forget after the stock plunged over 10% following the company’s latest quarterly earnings, which were reported after the close on Thursday. The stock is down over 13% in the last week.
While the sportswear giant posted a Q2 earnings and revenue beat, its sales in China declined, while U.S. tariffs are raising input costs, eating into margins.
“While F2Q results came in ahead, China/Converse results were far below Street/buyside expectations and further headwinds in both segments are pressuring the 3Q outlook,” wrote Truist analyst Joseph Civello in a note to clients.
“While progress is bumpy, we still think product improvements (primarily running with modest greenshoots in other categories so far) and expansions with existing/new retail partners show that the turnaround is trending in the right direction.”
Oracle
Oracle had a mixed week. Shares continued last week’s sell-off before some good news on Friday provided a boost.
The initial decline centered on data center concerns, with a Financial Times report stating that Blue Owl Capital had decided not to back a planned $10 billion facility in Michigan intended to serve OpenAI.
However, the company responded, saying that final negotiations on an equity deal for a Michigan data center project are “on schedule.” However, they do not include Blue Owl Capital.
While that was not enough to boost Oracle shares, a report on Friday that ByteDance has agreed to sell more than 80% of TikTok’s U.S. operations to a consortium that includes Oracle, Silver Lake, and Abu Dhabi-based MGX sent the stock more than 8% higher.
Rivian
Rivian shares surged on Thursday and Friday, putting it on course to close the week around 33.3% higher.
The increase comes after positive analyst commentary following its recent autonomy and AI day.
Baird analyst Ben Kallo upgraded the stock on Thursday, lifting the price target to $25 from $14 per share.
“We are upgrading RIVN to Outperform as we move into 2026, which is the year of the R2 launch,” Kallo wrote in a note. “We expect this to be a boost for RIVN’s brand, product demand, and thus by extension the stock as deliveries begin near mid-year,” he added.
“The recent Autonomy and AI day was highlighted by the unveiling of custom chips and a more thorough overview of RIVN’s autonomous strategy, which we view positively for long-term competitiveness.”
Amicus Therapeutics
Amicus Therapeutics is the last name on the list following news that BioMarin has agreed a deal to acquire the company for $14.50 per share in an all-cash transaction for a total equity value of approximately $4.8 billion.
FOLD shares jumped over 30% on Friday.
“BioMarin’s scale of operations, including our global commercial footprint and industry-leading, in-house manufacturing capabilities, make the combination of these companies an exceptional strategic fit," said Alexander Hardy, Chief Executive Officer of BioMarin.
The transaction is expected to close in the second quarter of 2026.
